Results 211 to 220 of about 31,542 (255)
Some of the next articles are maybe not open access.
Prostate Ductal Adenocarcinoma
Applied Immunohistochemistry & Molecular Morphology, 2018Prostate ductal adenocarcinoma (PDA) is a rare subtype of prostate adenocarcinoma that shows more aggressive behavior than conventional prostatic acinar adenocarcinoma. PDA demonstrates similar clinical and paraclinical features such as prostatic acinar adenocarcinoma; therefore, clinical distinction of the 2 entities is very difficult (if not ...
openaire +2 more sources
The Chemotherapy of Prostatic Adenocarcinoma
Annals of Internal Medicine, 1980A number of chemotherapeutic agents show moderate promise for the palliative treatment of metastatic prostatic carcinoma. Although patterns of metastatic disease make classic response rates difficult to obtain and interpret, doxorubicin, cyclophosphamide, dacarbazine (DTIC), and cisplatin have activity in patients who have failed conventional hormonal ...
F M, Torti, S K, Carter
openaire +2 more sources
Prostatic xanthoma: A mimic of prostatic adenocarcinoma
Human Pathology, 1994Xanthoma is a localized collection of cholesterol-laden histiocytes that is usually idiopathic, but may be seen in patients with hyperlipidemia. We report seven cases of xanthoma involving the prostate, including one arising in a patient with mild hyperlipidemia.
T J, Sebo +3 more
openaire +2 more sources
Pseudohyperplastic Adenocarcinoma of the Prostate
Journal of Urology, 2014A 60-year-old man underwent radical prostatectomy after a needle biopsy diagnosis of adenocarcinoma of the prostate with Gleason score 3 þ 3 1⁄4 6 in 4 of 12 cores. Sections of radical prostatectomy tissue showed areas with a somewhat nodular growth of complex glands resembling benign prostatic hyperplasia (fig. 1).
openaire +2 more sources
Ductal Adenocarcinoma of the Prostate
Journal of Urology, 2011Johann D, Hertel, Peter A, Humphrey
openaire +2 more sources
Adenocarcinoma of the prostate.
Journal of insurance medicine (New York, N.Y.), 1998Prostate cancer presents a growing challenge for the medical director. Knowledge of prostate cancer statistics, risk factors, stage and grade of the tumors, screening, and treatment options is necessary for underwriting and claims evaluation.
openaire +3 more sources
Mucinous Adenocarcinoma of the Prostate
Journal of Computer Assisted Tomography, 1982N R, Dunnick +4 more
openaire +2 more sources
Mucogenic Adenocarcinoma of the Prostate
Journal of Urology, 1967D P, Joshi, W H, Seery, C R, Neier
openaire +2 more sources